Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 1,004,050 | 1,004,050 | 0 | $26.11M | $40.44M | 37.19% | +$14.34M |
| Alumis Inc. | 5,779,348 | 5,779,348 | 0 | $17.34M | $23.06M | 21.21% | +$5.72M |
| Disc Medicine, Inc.(IRON) | 299,069 | 299,069 | 0 | $15.84M | $19.76M | 18.17% | +$3.92M |
| Hims & Hers Health, Inc.CL A(HIMS) | 273,151 | 273,151 | 0 | $13.62M | $15.49M | 14.25% | +$1.88M |
| Lyell Immunopharma, Inc.(LYEL) | 406,652 | 477,078 | +70,426 | $3.59M | $7.75M | 7.12% | +$4.15M |
| Maze Therapeutics, Inc.(MAZE) | 345,191 | 86,291 | -258,900 | $4.24M | $2.24M | 2.06% | -$2.00M |